Active, not recruitingNot applicableNCT04765592

Guo's Aortic Arch Reconstruction :The Prospective ,Multiple Center Study About the Safety and Efficacy of WeFlow-Arch Modeler Embedded Branch Stent Graft System (GIANT Study)

Studying Anorectal malformation

Last synced from ClinicalTrials.gov May 4, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Hangzhou Endonom Medtech Co., Ltd.
Intervention: WeFlow-Arch Modeler Embedded Branch Stent Graft System(device)
Enrollment: 88 target
Eligibility: 18-80 years · All sexes
Timeline: 2021 – 2029

Study locations (23)

Beijing Anzhen Hospital, Capital Medical University, Beijing, China
Chinese PLA General Hospital, Beijing, China
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China
Peking University People's Hospital, Beijing, China
Xiangya Hospital of Central South University, Changsha, China
West China Hospital of Sichuan University, Chengdu, China
The First Affiliated Hospital ,Sun Yat-sen University, Guangzhou, China
First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
The Second Affiliated Hospital of Harbin Medical University, Harbin, China
Shandong Provincial Hospital, Jinan, China
The First People's Hospital of Yunnan Province, Kunming, China
Nanjing Drum Tower Hospital, Nanjing, China
Nanjing First Hospital, Nanjing, China
The Affiliated Hospital Of Qingdao University, Qingdao, China
+8 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04765592 on ClinicalTrials.gov

Other trials for Anorectal malformation

Additional recruiting or active studies for the same condition.

See all trials for Anorectal malformation →

← Back to all trials